Sofi E. Eriksson

2.1k citations
17 papers · 1.8k · 1 hit paper · h-index 15

Impact in

  • Oncology top 5%
    • Cancer-related Molecular Pathways
    • Metal complexes synthesis and properties
    • Redox biology and oxidative stress
    • Cell death mechanisms and regulation
    • Genomics, phytochemicals, and oxidative stress

Papers in

    • Cancer-related Molecular Pathways 5
    • Redox biology and oxidative stress 9
    • RNA Research and Splicing 1

Sofi E. Eriksson

17 papers receiving 1.8k citations

Sofi E. Eriksson's Hit Papers

Targeting mutant p53 for efficient cancer therapy 2017 · 741 citations
7410+3+6Years since publication200400600

Peers

Sofi E. Eriksson
Comparison fields: 5 of 84
  • Oncology 438
  • Molecular Biology 739
  • Cancer Research 145
  • Nutrition and Dietetics 107
  • Toxicology 34
Replace Peijun He with:
Peijun He United States
Francesca Scrimieri United States
Kiyomu Fujii Japan
Helen B. Pearson Australia
Mohamed X. Ibrahim Sweden
Mouad Edderkaoui United States
Shuangping Liu China
Timothy J. Humpton United Kingdom
David A. Jones United States
Xianzhong Ding United States
Sofi E. Eriksson relative to Peijun He United States Peijun He's profile →
Citations per field
00.5×2×3×4×4.9×
Peijun He · 1×
Citations per year

Countries citing papers authored by Sofi E. Eriksson

Since Specialization
Citations

This map shows the geographic impact of Sofi E. Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofi E. Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofi E. Eriksson more than expected).

Fields of papers citing papers by Sofi E. Eriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofi E. Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofi E. Eriksson. The network helps show where Sofi E. Eriksson may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofi E. Eriksson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofi E. Eriksson Line = papers co-authored together Sofi E. Eriksson links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Targeting mutant p53 for efficient cancer therapy
Hit paper breakdown →
2017741
2 2014208
3 2009121
4 2019107
5 201592
6 201981
7 200970
8 201163
9 201362
10 200861
11 201544
12 201440
13 202035
14 201432
15 200923
16 202115
17 201512

About Sofi E. Eriksson

Sofi E. Eriksson is a scholar working on Oncology, Molecular Biology, Pharmacology, Nutrition and Dietetics and Geriatrics and Gerontology, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include Redox biology and oxidative stress (9 papers), Cancer-related Molecular Pathways (5 papers), Selenium in Biological Systems (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), RNA Research and Splicing (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Sirtuins and Resveratrol in Medicine (1 paper). The work is most often cited by research in Oncology (438 citations), Molecular Biology (739 citations), Cancer Research (145 citations), Nutrition and Dietetics (107 citations) and Toxicology (34 citations). Sofi E. Eriksson has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Klas G. Wiman, Vladimir J.N. Bykov, Julie Bianchi, Elias S.J. Arnér, Edward E. Schmidt, Justin R. Prigge, Elisabeth Hedström, Galina Selivanova, Joanna Zawacka‐Pankau and Sophia Ceder. Their work appears in journals such as Free Radical Biology and Medicine, Cell Death and Disease, Nature reviews. Cancer, Nature Communications and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact